Agios Pharmaceuticals Inc (AGIO) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Agios Pharmaceuticals Inc   (NASDAQ: AGIO)
 

Agios Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Agios Pharmaceuticals Inc 's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.2 in the first quarter 2026Average processing period, for Agios Pharmaceuticals Inc 's inventories remained unchanged at 1825 days, in the Mar 31 2026 quarter.

Within Healthcare sector 367 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1160 in the fourth quarter 2025, to 1163.

AGIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Agios Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGIO Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 18.52 % 19.21 % 21.21 % 28.87 % 28.33 %
Y / Y Cost of Sales Growth 21.57 % 49.13 % 114.43 % 13.85 % 73.05 %
Inventory Turnover Ratio (TTM) 0.2 0.2 0.19 0.17 0.17
AGIO's Total Ranking # 1163 # 1160 # 1662 # 518 # 1107
Average inventory processing period 1815 1804 1914 2163 2124
Seq. Inventory Growth 6.58 % 2.77 % 3.84 % 4.2 % 7.2 %
Seq. Cost of Sales Growth -29.8 % 11.91 % -1.35 % 56.87 % -13.89 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 115
Healthcare Sector # 368
Overall Market # 1163

Inventory Turnover Ratio Statistics
High Average Low
22.85 1.96 0.15
(Jun 30 2019)   (Sep 30 2024)



AGIO Company Profile >> Back to AGIO Efficiency Comparisons >> Compare AGIO Inventory Turnover Ratio to its Competitors

Financial Statements
Agios Pharmaceuticals Inc 's Inventories $ 35 Millions Visit AGIO's Balance sheet
Agios Pharmaceuticals Inc 's Cost of Revenues TTM $ 7 Millions Visit AGIO's Income Statement
What are AGIO's Sales? Visit AGIO's Sales by Segment

Other Inventory Turnover Ratios
Agios Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AGIO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AGIO's Competitors
Inventory Turnover Ratio for AGIO's Suppliers
Inventory Turnover Ratio for AGIO's Customers

You may also want to know
AGIO's Sales Growth Rates AGIO's Pe Price to earnings ratio AGIO's Receivables Turnover Ratio AGIO's Stock Quote
AGIO's Net Income Growth Rates AGIO's Ps Price to Sales ratio AGIO's Sales per Employee AGIO's Asset Turnover Ratio
AGIO's Net Margin AGIO's Pb Price to Book ratio AGIO's Financial Strength Ratios AGIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Orthopediatrics Corp  0.49 $ 64.000  Millions$ 130  Millions
Jaguar Health Inc   0.47 $ 4.417  Millions$ 9  Millions
X4 Pharmaceuticals Inc  0.40 $ 1.639  Millions$ 4  Millions
Clene Inc   0.40 $ 0.023  Millions$ 0  Millions
Outlook Therapeutics Inc   0.40 $ 1.408  Millions$ 4  Millions
Co diagnostics Inc   0.40 $ 0.399  Millions$ 1  Millions
Regeneron Pharmaceuticals Inc   0.39 $ 1,248.700  Millions$ 3,191  Millions
Soleno Therapeutics Inc  0.38 $ 3.898  Millions$ 10  Millions
Guided Therapeutics Inc   0.37 $ 0.196  Millions$ 1  Millions
Alpha Cognition Inc.  0.31 $ 1.300  Millions$ 4  Millions
Aditxt Inc   0.31 $ 0.012  Millions$ 0  Millions
Nexalin Technology Inc   0.31 $ 0.050  Millions$ 0  Millions
EBR Systems, Inc.  0.30 $ 3.305  Millions$ 11  Millions
Vystar Corporation  0.27 $ 0.017  Millions$ 0  Millions
Immunitybio inc   0.25 $ 0.933  Millions$ 4  Millions
Adagio Medical Holdings inc   0.23 $ 0.431  Millions$ 2  Millions
Agios Pharmaceuticals Inc   0.20 $ 6.579  Millions$ 33  Millions
Biocorrx Inc   0.17 $ 0.025  Millions$ 0  Millions
Bioadaptives Inc   0.17 $ 0.007  Millions$ 0  Millions
Femasys Inc   0.16 $ 0.914  Millions$ 6  Millions
Apellis Pharmaceuticals Inc   0.15 $ 20.000  Millions$ 129  Millions
Yubo International Biotech Limited  0.14 $ 0.004  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.05 $ 1.118  Millions$ 21  Millions
Ptc Therapeutics inc   0.05 $ 3.100  Millions$ 60  Millions
Invo Fertility Inc   0.04 $ 0.008  Millions$ 0  Millions

Date modified: 2026-08-29T17:23:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.